BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 25668503)

  • 1. Chemoprevention of breast cancer among women at elevated risk as defined by Gail Score.
    Micallef S; Micallef D; Schembri-Wismayer P; Brincat MP; Calleja-Agius J
    Minerva Ginecol; 2015 Aug; 67(4):335-52. PubMed ID: 25668503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Breast Cancer Chemoprevention among High-risk Women and those with Ductal Carcinoma In Situ.
    Reimers LL; Sivasubramanian PS; Hershman D; Terry MB; Greenlee H; Campbell J; Kalinsky K; Maurer M; Jayasena R; Sandoval R; Alvarez M; Crew KD
    Breast J; 2015; 21(4):377-86. PubMed ID: 25879521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endocrine therapy for breast cancer prevention in high-risk women: clinical and economic considerations.
    Groom AG; Younis T
    Expert Rev Pharmacoecon Outcomes Res; 2016; 16(2):245-55. PubMed ID: 26923683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel concepts for the chemoprevention of breast cancer through aromatase inhibition.
    Kendall A; Dowsett M
    Endocr Relat Cancer; 2006 Sep; 13(3):827-37. PubMed ID: 16954432
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Breast cancer prevention.
    Euhus DM; Diaz J
    Breast J; 2015; 21(1):76-81. PubMed ID: 25413630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemoprevention of hormone receptor-negative breast cancer: new approaches needed.
    Uray IP; Brown PH
    Recent Results Cancer Res; 2011; 188():147-62. PubMed ID: 21253797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemoprevention in the 21st century: is a balance best or should women have no estrogen at all?
    Jordan VC
    J Clin Oncol; 2005 Mar; 23(8):1598-600. PubMed ID: 15755960
    [No Abstract]   [Full Text] [Related]  

  • 8. Addressing barriers to uptake of breast cancer chemoprevention for patients and providers.
    Crew KD
    Am Soc Clin Oncol Educ Book; 2015; ():e50-8. PubMed ID: 25993215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Breast Cancer Chemoprevention: A Practical Guide for the Primary Care Provider.
    Farkas A; Vanderberg R; Merriam S; DiNardo D
    J Womens Health (Larchmt); 2020 Jan; 29(1):46-56. PubMed ID: 31560601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Breast cancer chemoprevention: old and new approaches.
    Cazzaniga M; Bonanni B
    J Biomed Biotechnol; 2012; 2012():985620. PubMed ID: 22851887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Breast cancer prevention by antihormones and other drugs: where do we stand?
    Lazzeroni M; DeCensi A
    Hematol Oncol Clin North Am; 2013 Aug; 27(4):657-72, vii. PubMed ID: 23915737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Breast cancer prevention in high-risk women: searching for new options.
    Nelson NJ
    J Natl Cancer Inst; 2011 May; 103(9):710-1. PubMed ID: 21515834
    [No Abstract]   [Full Text] [Related]  

  • 13. Chemoprevention of breast cancer.
    Castrellon AB; Glück S
    Expert Rev Anticancer Ther; 2008 Mar; 8(3):443-52. PubMed ID: 18366291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemoprevention of breast cancer: current status and future prospects.
    Zhao X; Li L; Wang Z
    Front Biosci; 2006 Sep; 11():2249-56. PubMed ID: 16720311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SERMs in chemoprevention of breast cancer.
    Gasco M; Argusti A; Bonanni B; Decensi A
    Eur J Cancer; 2005 Sep; 41(13):1980-9. PubMed ID: 15964182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical use of selective estrogen receptor modulators and down regulators with the main focus on breast cancer.
    Baumann CK; Castiglione-Gertsch M
    Minerva Ginecol; 2009 Dec; 61(6):517-39. PubMed ID: 19942839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aromatase inhibitors in the breast cancer therapy and their potential using in the prevention setting.
    Kubatka P; Sadlonova V; Nosalova G; Sadlonova J
    Bratisl Lek Listy; 2007; 108(6):271-5. PubMed ID: 17972540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Future use of selective estrogen receptor modulators and aromatase inhibitors.
    Howell A
    Clin Cancer Res; 2001 Dec; 7(12 Suppl):4402s-4410s; discussion 4411s-4412s. PubMed ID: 11916232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Breast cancer prevention: lifestyle changes and chemoprevention.
    Lambrechts S; Decloedt J; Neven P
    Acta Clin Belg; 2011; 66(4):283-92. PubMed ID: 21938984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemoprevention of breast cancer.
    O'Regan RM
    Lancet; 2006 Apr; 367(9520):1382-3. PubMed ID: 16650636
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.